Prot #68284528MMY2005: A Safety and Efficacy Study of JNJ-68284528 (ciltacabtagene autoleucel) Out-of-Specification (OOS) for Commercial Release in Patients with Multiple Myeloma

Project: Research project

Project Details

StatusActive
Effective start/end date5/25/22 → 12/8/25

Funding

  • Janssen Research & Development, LLC (Prot #68284528MMY2005)